Exchange: NASDAQ·Updated 09:03 AM EDT
AMGN logo

AMGN AMGEN Inc.

$386.10
$0.45
(0.12%)
Pre-Market
Prev Close $385.65
EarningsNov 3
Mkt Cap$208.49B
Vol5,882.00

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
38

Bearish Sentiment

How do you feel about AMGN?

Advertisement|Remove ads.